Acrotech Drug Patent Portfolio
Acrotech owns 1 orange book drug protected by 6 US patents Given below is the list of Acrotech's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7247316 | Compositions and methods for treating lymphoma | 25 Sep, 2020 | Expired |
| US6723338 | Compositions and methods for treating lymphoma | 31 Mar, 2020 | Expired |
| US7887836 | Compositions and methods for treating lymphoma | 31 Mar, 2020 | Expired |
| US5543152 | Sphingosomes for enhanced drug delivery | 20 Jun, 2014 | Expired |
| US5741516 | Sphingosomes for enhanced drug delivery | 20 Jun, 2014 | Expired |
| US5814335 | Sphingosomes for enhanced drug delivery | 20 Jun, 2014 | Expired |
Latest Legal Activities on Acrotech's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Acrotech.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 20 Mar, 2023 | US7887836 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Oct, 2022 | US7887836 |
| 11.5 yr surcharge- late pmt w/in 6 mo, Small Entity | 28 Jan, 2019 | US7247316 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 28 Jan, 2019 | US7247316 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Aug, 2018 | US7887836 |
| Notice of Final Determination- Ineligible | 31 Mar, 2015 | US7887836 |
|
Email Notification
Critical
| 12 Feb, 2015 | US7247316 |
| Filing Receipt - Corrected | 12 Feb, 2015 | US7247316 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 12 Feb, 2015 | US7247316 |
|
Correspondence Address Change
Critical
| 11 Feb, 2015 | US7247316 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 05 Feb, 2015 | US7247316 |
| Letter from FDA or Dept of Agriculture re PTE application | 31 Jan, 2014 | US7887836 |
| Initial letter Re: PTE Application to regulating agency | 19 Jun, 2013 | US7887836 |
| Patent Term Extension Application under 35 USC 156 Filed | 05 Oct, 2012 | US7887836 |
|
Case Docketed to Examiner in GAU
Critical
| 01 Mar, 2012 | US7247316 |
Acrotech's Family Patents
Acrotech Drug List
Given below is the complete list of Acrotech's drugs and the patents protecting them.
1. Marqibo Kit
Marqibo Kit is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7247316 | Compositions and methods for treating lymphoma |
25 Sep, 2020
(4 years ago)
| Expired |
| US6723338 | Compositions and methods for treating lymphoma |
31 Mar, 2020
(4 years ago)
| Expired |
| US7887836 | Compositions and methods for treating lymphoma |
31 Mar, 2020
(4 years ago)
| Expired |
| US5543152 | Sphingosomes for enhanced drug delivery |
20 Jun, 2014
(10 years ago)
| Expired |
| US5741516 | Sphingosomes for enhanced drug delivery |
20 Jun, 2014
(10 years ago)
| Expired |
| US5814335 | Sphingosomes for enhanced drug delivery |
20 Jun, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Marqibo Kit's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List